TY  - JOUR
AU  - Giménez-Arnau, Ana
AU  - Velasco, Manel
AU  - Armario Hita, Jose Carlos
AU  - Labrador-Horrillo, Moises
AU  - Silvestre Salvador, Juan Francisco
PY  - 2016
DO  - 10.1684/ejd.2016.2809
UR  - http://hdl.handle.net/10668/10114
T2  - European journal of dermatology : EJD
AB  - Chronic spontaneous urticaria (CSU) is a skin disease characterised by wheal appearance, swelling, itching, and painful skin. Omalizumab has been used for CSU treatment demonstrating good efficacy. To investigate the efficacy and safety of omalizumab...
LA  - en
KW  - chronic urticaria
KW  - efficacy
KW  - health care
KW  - omalizumab
KW  - safety
KW  - Adult
KW  - Anti-Allergic Agents
KW  - Chronic Disease
KW  - Emergency Service, Hospital
KW  - Female
KW  - Health Care Costs
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Office Visits
KW  - Omalizumab
KW  - Primary Health Care
KW  - Retrospective Studies
KW  - Treatment Outcome
KW  - Urticaria
TI  - Omalizumab: what benefits should we expect?
TY  - research article
VL  - 26
ER  -